|MDACC Study No:||2014-0052(2013-0684SOLIDTUMORS) (clinicaltrials.gov NCT No: NCT01829971)|
|Title:||A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection|
|Principal Investigator:||Jorge Cortes|
|Study Description:||The goal of this clinical research study is to find the highest tolerable dose |
of MRX34 that can be given to patients with various types of cancers of the
blood. The safety of this drug will also be studied.